Company CVAbout Fervent Synergies Ltd 
Fervent Synergies Ltd
Micro Cap
Pharmaceuticals & Drugs
Fervent Synergies Ltd was formerly incorporated as Fervent Pharma Synergies Ltd on July 6, 2009 and obtained Certificate of Commencement of Business on August 13, 2009. Thereafter, the name of the Company was changed from Fervent Pharma Synergies Limited to Fervent Synergies Ltd with effect from 24th July, 2012.
Company Coordinates
Company Details
B-7/8 Satyam Commercial Comple, M G Road Ghatkopar (East) Mumbai Maharashtra : 400077
Registrar Details
Sharex Dynamic (India) Pvt Ltd , Unit -1, Luthra Ind. Premises , Safed Pool, Andheri-Kurla Road, Andheri (E), Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 30.00 Cr
Number of Shares
3 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
29-May-2014
3
30.00
5000000
10
Allotment of Equity To Others
29-May-2014
3
30.00
5000000
10
Allotment of Equity To Others
04-Jul-2011
2.5
25.00
20000000
10
Amalgamation
04-Jul-2011
2.5
25.00
20000000
10
Amalgamation
08-Feb-2010
5
5.00
4950000
10
Allotment of Equity Shares To Promoter & Others
08-Feb-2010
5
5.00
4950000
10
Allotment of Equity Shares To Promoter & Others
06-Jul-2009
5
0.05
50000
10
Subscription to the Memorandum of Association
06-Jul-2009
5
0.05
50000
10
Subscription to the Memorandum of Association
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Vijay Thakkar (57.49%)
Highest Public shareholder
Blue Berry Securities Pvt Ltd (5.66%)
Individual Investors Holdings
12.34%
Board of Directors
Management
Designation
Remuneration
Vijay P Thakkar
Chairman/ED & CEO
0
Karan V Thakkar
Executive Director & CFO
6.0 lacs
Sanjay P Thakkar
ED / MD / Promoter
6.0 lacs
Nitin B Parikh
Independent Non Exe. Director
0
Rajesh M Maheshwari
Independent Non Exe. Director
0
Falguni Kaushik Mehta
Independent Non Exe. Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchase
14.67794
0%
Purchase
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Other Operating Revenues - Interest
1.91
11.48%
Other Operating Revenues - Interest
Other Operating Revenues - Interest
Stock DNARevenue and Profits:
Net Sales:
26 Cr
(Quarterly Results - Dec 2024)
Net Profit:
2 Cr
Pharmaceuticals & Drugs
INR 94 Cr (Micro Cap)
NA (Loss Making)
33
0.00%
0.00
-30.85%
2.66
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
